Products

Signal Tracker Data Platform Data Enrichment API Intelligence desk

Solutions

Inward Investment & Aftercare Deal Origination Executive Search Corporate Development Signal-Based Outbound Competitive Intelligence Funding Signals Competitor Monitoring For Sales Teams For Founders For Agencies For Investors

Explore

Companies Live Signals Markets Trends

Resources

Signal Checker Blog Integrations FAQ Contact
Login Book a demo
SilkTech Biopharmaceuticals logo — VC-backed biotech Company with several patented silk protein...

SilkTech Biopharmaceuticals

VC-backed biotech Company with several patented silk protein-derived anti inflammatory therapies in FDA Clinical Trials.

Founded 2013 United States Plymouth, United States 5 employees Series B Total: $17.20M Biotechnology, Health Care

General Information

Company Name SilkTech Biopharmaceuticals
Founded Year 2013
Location United States Plymouth, United States
Employees 5
Industries Biotechnology, Health Care
Funding Stage Series B
Business Model B2B, White Label
Revenue Model Licensing, Product Sales, Project Based
Social

BounceWatch is an independent company data service, not affiliated with SilkTech Biopharmaceuticals. To contact SilkTech Biopharmaceuticals, visit silk-tech.com.

Is this your company?

Confirm with your work e-mail, get the Verified badge and keep this profile correct yourself. Search engines and AI assistants read it every day.

Get Verified

How does SilkTech Biopharmaceuticals compare?

A PDF of SilkTech Biopharmaceuticals and up to 10 competitors you pick: team, funding, traffic and every dated move of the last 90 days. Each company is re-checked on the day you order, so it is current.

See a sample report

This takes a few seconds: we look beyond our own index too.

Meeting SilkTech Biopharmaceuticals soon?

A one-page PDF brief: what it does, key facts, the last 90 days of dated moves and questions worth asking. Re-checked on the day you order. See a sample

About SilkTech Biopharmaceuticals

SilkTech Biopharmaceuticals, founded in 2013, stands as a pioneering force in the intersections of Biotechnology and Health Care. Headquartered in the United States, the company specializes in developing silk-based anti-inflammatory therapies, targeting conditions like Dry Eye Disease - a chronic inflammatory ailment.

Known for being a VC-backed entity, SilkTech is notable for having multiple patented silk protein-derived formulations currently progressing through FDA Clinical Trials. This strategic focus not only highlights their commitment to innovative treatments but also underscores the growth potential within this niche segment of biopharmaceuticals.

The company's most recent financial milestone occurred on April 16, 2019, when it secured a $6.20M Series B investment from Skyview Capital. This injection of capital is a testament to investor confidence in SilkTech's scientific expertise and market potential, positioning it as a significant player to watch in biotech innovation.

Business keywords: ophthalmology, innovation, startup, silk-derived protein, dry eye disease, medical research, investors, Plymouth, MN, angel investors, grants, funding round, Skyview Ventures, eye care

Services & Products

Product Development Assistance
Proprietary Database Access
Patented Technology Access
Silk Product Design
Product Enhancement

Target Customers

Medical Device Manufacturers Pharmaceutical Companies Cosmetic Brands Food & Beverage Companies Animal Health Product Developers

Funding Rounds & Investors (2)

View All
Funding Stage Amount Investors Lead Investors Date
Series B $6.20M 1
Skyview Capital
Skyview Capital
16 Apr 2019
Series A $11.00M 1
Skyview Capital
Skyview Capital
01 Oct 2017

SilkTech Biopharmaceuticals Alternatives & Competitors

SilkTech Biopharmaceuticals vs
LENTECHS
LENTECHS United States

Developing a new generation of soft, suspended contact lens

Venture round
9 employees
Biotechnology, Health Care
SilkTech Biopharmaceuticals vs
Restore Vision
Restore Vision Japan

Creating a next vision

Series A
7 employees
Biotechnology, Health Care
SilkTech Biopharmaceuticals vs
Aurion Biotech
Aurion Biotech United States

We're on a mission to cure blindness with our transformational platform of advanced therapies

Acquired
94 employees
Biopharma, Biotechnology

FAQ About SilkTech Biopharmaceuticals

VC-backed biotech Company with several patented silk protein-derived anti inflammatory therapies in FDA Clinical Trials.
SilkTech Biopharmaceuticals was founded in 2013.
SilkTech Biopharmaceuticals is headquartered in Plymouth, United States.
SilkTech Biopharmaceuticals operates in Biotechnology and Health Care. Its work centres on ophthalmology, innovation, startup and silk-derived protein. Its customers include Medical Device Manufacturers, Pharmaceutical Companies and Cosmetic Brands.
SilkTech Biopharmaceuticals has a B2B and White Label business model. Its revenue comes from Licensing, Product Sales and Project Based.
SilkTech Biopharmaceuticals has approximately 5 employees.
SilkTech Biopharmaceuticals has completed 2 funding rounds, raising a total of $17.20M. The latest funding stage is Series B.
SilkTech Biopharmaceuticals offers: Product Development Assistance, Proprietary Database Access, Patented Technology Access, Silk Product Design, Product Enhancement.
Top alternatives and competitors to SilkTech Biopharmaceuticals include LENTECHS, Restore Vision, Aurion Biotech, Opterion Health AG, ReNewVax Ltd. These companies operate in related industries and serve comparable markets. You can compare them side by side on Bounce Watch.
SilkTech Biopharmaceuticals and LENTECHS are both companies in similar industries. Compare their funding, team size, growth signals, and market position on Bounce Watch to see which one fits your needs.

Source: BounceWatch company record for SilkTech Biopharmaceuticals, https://bouncewatch.com/company/silk-technologies, updated 18 July 2026. When citing, please name BounceWatch and link this page.

Analytics cookies (ours + Google). Cookie Policy

Book a demo 30 minutes